Coreg cr and Chronic obstructive pulmonary disease - a phase IV clinical study of FDA data

Summary:

Chronic obstructive pulmonary disease is reported as a side effect among people who take Coreg cr (carvedilol phosphate), especially for people who are female, 60+ old, also take Calcium, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Chronic obstructive pulmonary disease when taking Coreg cr. It is created by eHealthMe based on reports of 1,401 people who have side effects when taking Coreg cr from the FDA, and is updated regularly.

What is Coreg cr?

Coreg cr has active ingredients of carvedilol phosphate. It is often used in high blood pressure. eHealthMe is studying from 1,628 Coreg cr users. Check the latest studies of Coreg cr.

What is Chronic obstructive pulmonary disease?

Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe) is found to be associated with 1,799 drugs and 2,209 conditions by eHealthMe. Check the latest studies of Chronic obstructive pulmonary disease.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

1,401 people reported to have side effects when taking Coreg cr.
Among them, 12 people (0.86%) have Chronic obstructive pulmonary disease.

Could Coreg cr cause Chronic obstructive pulmonary disease?

Among these 12 people:

What is the gender of people who have Chronic obstructive pulmonary disease when taking Coreg cr? *

female: 83.33 %
male: 16.67 %

What is the age of people who have Chronic obstructive pulmonary disease when taking Coreg cr? *

What are other drugs people take besides Coreg cr? *

What are other side effects people have besides Chronic obstructive pulmonary disease? *

Dyspnea (difficult or laboured breathing): 8 people, 66.67%
Weight Increased: 7 people, 58.33%
Chest Pain: 7 people, 58.33%
Headache (pain in head): 7 people, 58.33%
Fall: 7 people, 58.33%
White Blood Cell Count Decreased: 6 people, 50.00%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 6 people, 50.00%
Neck Pain: 6 people, 50.00%
Lung Infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung): 6 people, 50.00%
Wheezing (a high-pitched whistling sound made while you breath): 6 people, 50.00%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 6 people, 50.00%
Scar: 1 person, 8.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 8.33%
Asthma: 1 person, 8.33%
Blood Potassium Decreased: 1 person, 8.33%
Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 1 person, 8.33%
Cardiac Disorder: 1 person, 8.33%
Cardiac Failure Congestive: 1 person, 8.33%
Depression: 1 person, 8.33%
Diabetes: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Coreg cr and have Chronic obstructive pulmonary disease?

- Check whether Chronic obstructive pulmonary disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Coreg cr:

Coreg cr (1,628 reports)

Browse all side effects of Coreg cr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Chronic obstructive pulmonary disease:

Chronic obstructive pulmonary disease (1,799 drugs)

Browse all the conditions that are associated with Chronic obstructive pulmonary disease:

Chronic obstructive pulmonary disease (2,209 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on carvedilol phosphate (the active ingredients of Coreg cr) and Coreg cr (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.